Pronucleotein Biotechnologies Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Pronucleotein Biotechnologies General Information

Description

Developer of deoxyribonucleic acid aptamer sequences and conjugates. The company's diagnostic platform for development and commercialization of a new food safety testing system can be used at any point in the global food supply chain, and provide results onsite within 30 minutes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4100 North West Loop 410
  • Suite 230
  • San Antonio, TX 78229
  • United States
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • 4100 North West Loop 410
  • Suite 230
  • San Antonio, TX 78229
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pronucleotein Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial

Pronucleotein Biotechnologies Patents

Pronucleotein Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120094277-A1 Methods of producing competitive aptamer fret reagents and assays Inactive 29-Jan-2008
US-20090186342-A1 Methods of producing competitive aptamer fret reagents and assays Inactive 12-May-2006
US-20120270221-A1 Methods of sequencing fluorophore-quencher fret-aptamers Inactive 12-May-2006
US-20120219961-A1 Methods of running assays using intrachain fluorophore-quencher fret-aptamers Inactive 12-May-2006
US-20140011200-A1 Methods of producing competitive aptamer fret reagents and assays Inactive 13-May-2005 C12Q1/6804
To view Pronucleotein Biotechnologies’s complete patent history, request access »

Pronucleotein Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial

Pronucleotein Biotechnologies FAQs

  • When was Pronucleotein Biotechnologies founded?

    Pronucleotein Biotechnologies was founded in 2005.

  • Where is Pronucleotein Biotechnologies headquartered?

    Pronucleotein Biotechnologies is headquartered in San Antonio, TX.

  • What industry is Pronucleotein Biotechnologies in?

    Pronucleotein Biotechnologies’s primary industry is Other Healthcare Services.

  • Is Pronucleotein Biotechnologies a private or public company?

    Pronucleotein Biotechnologies is a Private company.

  • What is Pronucleotein Biotechnologies’s current revenue?

    The current revenue for Pronucleotein Biotechnologies is .

  • Who are Pronucleotein Biotechnologies’s investors?

    Texas Emerging Technology Fund has invested in Pronucleotein Biotechnologies.

  • When was Pronucleotein Biotechnologies acquired?

    Pronucleotein Biotechnologies was acquired on 14-Aug-2017.

  • Who acquired Pronucleotein Biotechnologies?

    Pronucleotein Biotechnologies was acquired by Seek Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »